In-licensing

Innovative consumer products company seeking OTC opportunities in the intimate female health category. Prefer proprietary, patent or NDA protected opportunities with demonstrated safety and efficacy.

Wisconsin Pharmacal Company is a leading manufacturer, marketer, and distributor of innovative female healthcare products under its proprietary brands including vH essentials® and YeastGard®.

Our goal in developing new female healthcare products is to offer women more control over their urogenital health and sexual well-being. Therefore, we are most interested in reviewing product opportunities or technologies for development that can help women to: maintain vaginal/urinary tract health and reduce frequency of common vaginal/urinary tract infections/symptoms; accurately self-diagnose common vaginal symptoms, and; effectively self-treat the most common vaginal/urinary tract infections or manage the most bothersome symptoms.

Highest priority will be placed on proprietary opportunities that are patented, or otherwise competitively protected, with demonstrated safety and effectiveness for vaginal/urinary tract health application.
In addition to our interest in already established female healthcare products with demonstrated market success, we have interest in evaluating opportunities for development of novel technologies that can innovate the female health category and empower the female consumer. Valuable innovations could take many forms, including:
• New delivery formats: erodible bioadhesive films; bioadhesive gels or foams; bioadhesive tablets or ovules; novel vaginal applicators; etc.

• New actives, excipients or formulations featuring: improved efficacy; fast acting; sustained pH lowering and pH buffering activity; one day only treatment; sustained release properties; no leak/no mess characteristics; etc.

• Natural or botanical products with clinical evidence of safety and efficacy

Wisconsin Pharmacal Company has a proven track record of rapidly developing and bringing to market innovative female healthcare products based upon both in-licensed and acquired technologies.

Patent information -

Strong preference for proprietary opportunities that are patented, patent pending, or otherwise competitively protected.

Please note - Open to all stages of development, but if early stage, then strong preference for patent or patent pending opportunity with data available to substantiate safety and efficacy.

Early Stage

Preference is acquisition or license, but open to discuss all forms of potential collaboration including acquisition, licensing, co-development and co-marketing.